Rare Disease Therapeutics · Cell & Gene Therapy
Sarepta revenue, results and funding
Sarepta filed revenue of $2.2B for 2025.
Data updated Nov 18, 2026 · Back to the company report
$2.2BRevenue, 2025
−$713.4MNet income, 2025
Results by year
| Year | Revenue | Net income | Total assets | LANG_CR_S_M_TAX_PAID | LANG_CR_S_M_TAX_EXPENSE | LANG_CR_S_M_BUYBACKS | LANG_CR_S_M_CAPEX | LANG_CR_S_M_SBC | LANG_CR_S_M_RND | LANG_CR_S_M_OPERATING_INCOME | LANG_CR_S_M_CASH | LANG_CR_S_M_DEBT | LANG_CR_S_M_ACQUISITIONS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $2.2B | −$713.4M | $3.3B | $37.6M | $11.2M | $25M | $102M | $123.4M | $1.5B | −$699.8M | $801.3M | $829M | – |
| 2024 | $1.9B | $235.2M | $4B | $22.6M | $25.5M | $0 | $137M | $184.3M | $804.5M | $218.1M | $1.1B | $1.1B | – |
| 2023 | $1.2B | −$536M | $3.3B | $15.1M | $15.9M | $0 | $76.1M | $182.5M | $877.4M | −$267.8M | $428.4M | $1.2B | – |
| 2022 | $933M | −$703.5M | $3.1B | $1.7M | $13.5M | – | $30.8M | $233M | $877.1M | −$536.2M | $966.8M | $1.5B | – |
| 2021 | $701.9M | −$418.8M | $3.1B | $583k | −$168k | – | $38.5M | $113.9M | $771.2M | −$459.7M | $2.1B | $563.7M | – |
| 2020 | $540.1M | −$554.1M | $3B | $2.5M | $1.1M | – | $82.2M | $108.1M | $722.3M | −$564.2M | $1.5B | – | – |
| 2019 | $380.8M | −$715.1M | $1.8B | $933k | $1.2M | – | $59.6M | $78.6M | $560.9M | −$705.6M | $835.1M | – | $172.6M |
| 2018 | $301M | −$361.9M | $1.6B | $1.5M | −$692k | – | $61.2M | $50.1M | $401.8M | −$343.6M | $370.8M | $420.6M | – |
| 2017 | $154.6M | −$50.7M | $1.3B | $5.3M | $2.1M | – | $12M | $30.5M | $166.7M | −$171.6M | $599.7M | $431.1M | – |
| 2016 | $5.4M | −$267.3M | $424.1M | – | – | – | $5.3M | $30M | $188.3M | −$266.7M | $122.4M | $17.7M | – |
| 2015 | $1.3M | −$220M | $273.8M | – | – | – | $3.4M | $32.1M | $146.4M | −$220.2M | $80.3M | $26.8M | – |
| 2014 | $9.8M | −$135.8M | $295M | – | – | – | $25.4M | $20.3M | $94.2M | −$133.8M | $73.6M | $1.5M | – |
| 2013 | – | −$112M | $291.6M | – | – | – | $2.4M | $11.1M | $72.9M | −$90.3M | $257M | $1.6M | – |
| 2012 | – | −$121.3M | $205M | – | – | – | $108k | $3.1M | $52.4M | −$29.7M | $187.7M | $1.7M | – |
| 2011 | – | −$2.3M | $54.4M | – | – | – | $1.2M | $3.1M | $66.9M | −$35.9M | $39.9M | $1.8M | – |
Sources: SEC
How to cite
Sarepta, Financials. Alion, Nov 18, 2026. https://alion.io/company/sarepta/financials
